Having trouble accessing articles? Reset your cache.

Genzyme up again on sanofi reports

Genzyme Corp. (NASDAQ:GENZ) gained $1.79 to $69.79 on Thursday after media reports surfaced that the board of sanofi-aventis Group (Euronext:SAN;

Read the full 206 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE